Laurus Labs Share Price Target: Global brokerage firm Goldman Sachs has maintained a cautious stance regarding pharma company Laurus Labs. While maintaining its ‘Sell’ rating on the stock, the brokerage has increased its target price from Rs 875 to Rs 900. However, Goldman Sachs believes that despite the improvement in the company’s recent results, earnings quality remains weak and current valuations are still expensive.
Laurus Labs Share Price Target: Goldman Sachs maintains Sell rating; Know what is the new target? – market
